• About us
  • Contact us
Thursday, June 4, 2026
No 1 epaper in Sri Lanka
  • News
  • Politics
  • Sports
  • Foreign
  • Entertainment
  • Business
  • Political Analysis
  • Inside Politics
  • EPAPERPDF
  • සිංහලSINHALA
No Result
View All Result
  • News
  • Politics
  • Sports
  • Foreign
  • Entertainment
  • Business
  • Political Analysis
  • Inside Politics
  • EPAPERPDF
  • සිංහලSINHALA
No Result
View All Result
Mawratanews.lk | Sri Lanka Latest Sinhala News and Headlines
No Result
View All Result
Home Business

Hemas Partners Oproma to Roll Out ‘Hair Buddy’ Online Brand

October 8, 2025
in Business
Reading Time: 12 mins read
A A
Hemas Partners Oproma to Roll Out ‘Hair Buddy’ Online Brand
Share on FacebookShare on Twitter

Hemas Pharmaceuticals (Pvt) Ltd, Sri Lanka’s market leader in pharmaceutical distribution, a subsidiary under Hemas Holdings PLC, recently announced the arrival of its latest hair care product with the launch of Hair Buddy. Developed in partnership with Oproma Cosmetics Pvt Ltd as a botanical fusion hair masque, Hair Buddy marks a milestone for Hemas Pharmaceuticals as its first-ever direct-to-consumer, digital-first launch.

NMRA approved and dermatologically tested, and 100% BPA free, Hair Buddy works rapidly to deliver visible growth. Designed to be a ‘forever friend’, Hair Buddy works to prevent hair loss, reduce dandruff, and strengthen hair from root to tip. Hair Buddy is uniquely positioned to build long-term scalp health through deep nourishment. Recommended for ages 16 and above, Hair Buddy’s ‘forever friend’ factor stems from its status as a safe, inclusive, and effective hair growth partner developed from time-tested Sri Lankan traditions based on plant-powered formulas.

Hair Buddy’s launch aligns with Hemas Pharmaceutical’s priority pillars by driving growth through entry into the fast-expanding hair care market. The launch of Hair Buddy represents both Hemas Pharmaceuticals’ diversification into personal care and cements its digital transformation agenda with a dedicated e-commerce platform offering convenient island-wide delivery.

Central to this latest milestone is Hemas Pharmaceuticals’ long-standing distribution partner for over two decades, Chandrasiri & Sons, who will serve as the exclusive distributor for Hair Buddy. With several years of partnership behind them, the collaboration underscores Hemas Pharmaceuticals’ commitment to building on trusted relationships as it explores new markets and consumer segments.

Speaking on the launch, Dr Mahesha Ranasoma, Managing Director of Hemas Pharmaceuticals, said, “As we continue to expand into new markets and healthcare categories, we’re not only pleased to renew and reaffirm longstanding and trusted partnerships, but we’re also eager to bring our customers a product that’s rooted in responsibility and free from harsh chemicals. Furthermore, Hair Buddy reflects Hemas Pharmaceutical’s focus on innovation, purpose, and ethically sustainable responsibility. Through Hair Buddy, Hemas Pharmaceuticals takes a meaningful step beyond healthcare into the realm of personal well-being.”

Mr. Pradeep Mapalagama, Managing Director of Oproma Cosmetics, added, saying, “With Hair Buddy, we aim to introduce customers to a holistic and carefully curated product that will ensure long-term hair care and profound customer satisfaction. Partnering with Hemas Pharmaceuticals ensures we not only bring this vision to life, but that it upholds and aligns with the same values of responsibility and innovation that we both share.”

To empower customers with a forever friend to keep them in control of hair fall and scalp health, the release of Hair Buddy highlights Hemas Pharmaceuticals’ purpose of enabling customers to live well through trusted innovation.

Image caption – (Left to right)

Hashan Perera, Director, Chandrasiri Distributors; Chandrasiri Perera, Chairman, Chandrasiri Distributors; Pradeep Mapalagama, Managing Director, Oproma Cosmetics; Dr Mahesha Ranasoma, Managing Director, Hemas Pharmaceuticals; Chinthaka Perera, Director of Sales, Hemas Pharmaceuticals; and Erandika Hennedige, Director of Business Development and Corporate Affairs, Hemas Pharmaceuticals.

Share51Tweet32Send
Previous Post

SLIC General champions road safety with unprecedented ‘I Am a Safe Driver’ national drive on World Children’s Day

Next Post

Is the government of AKD too caught in Chinese debt trap?

MORE NEWS

Sinque numberless patient monitoring solution by top Sri Lankan software outsourcing company is now being tested by US hospital chain.
Business

Sinque numberless patient monitoring solution by top Sri Lankan software outsourcing company is now being tested by US hospital chain.

June 4, 2026
Eswaran Brothers Empowers Women through a Transformative Leadership Journey
Business

Eswaran Brothers Empowers Women through a Transformative Leadership Journey

June 4, 2026
Gamer.LK’s Women’s Cyber Games 2026 powered by Maggi Papare Blast Wraps Up Another Thrilling Showcase of Female Esports Talent
Business

Gamer.LK’s Women’s Cyber Games 2026 powered by Maggi Papare Blast Wraps Up Another Thrilling Showcase of Female Esports Talent

June 4, 2026
Siyapatha Finance Expands Footprint with Boralesgamuwa Branch Opening
Business

Siyapatha Finance Expands Footprint with Boralesgamuwa Branch Opening

June 4, 2026
People’s Leasing & Finance PLC Now in Bibile
Business

People’s Leasing & Finance PLC Now in Bibile

June 4, 2026
Kaspersky detected more than 92,000 malware attacks disguised as AI services in 2026
Business

Kaspersky detected more than 92,000 malware attacks disguised as AI services in 2026

June 3, 2026
Load More

One of the best Sri Lanka Latest News Website and Sinhala language newspaper with Sunday editions, published by Free Media Independent Networks Pvt Ltd.

  • About us
  • Contact us

Copyright © 2019–2025 Free Media Independent Networks Pvt Ltd. All Rights Reserved. Developed by Turn Global.

No Result
View All Result
  • News
  • Politics
  • Sports
  • Foreign
  • Entertainment
  • Business
  • Political Analysis
  • Inside Politics
  • EPAPER
  • සිංහල

Copyright © 2019–2025 Free Media Independent Networks Pvt Ltd. All Rights Reserved. Developed by Turn Global.